TREATMENT OF THE PREMENSTRUAL SYNDROME

  1. Kathleen Robinson Consultant Obstetrician and Gynaecologist1,
  2. Kathleen M. Huntington Medical Practitioner Chelsea2,
  3. M. G. Wallace Clinical Trials Co-ordinator2

Article first published online: 23 AUG 2005

DOI: 10.1111/j.1471-0528.1977.tb12493.x

Issue

BJOG: An International Journal of Obstetrics & Gynaecology

BJOG: An International Journal of Obstetrics & Gynaecology

Volume 84, Issue 10, pages 784–788, October 1977

Additional Information

How to Cite

Robinson, K., Huntington, K. M. and Wallace, M. G. (1977), TREATMENT OF THE PREMENSTRUAL SYNDROME. BJOG: An International Journal of Obstetrics & Gynaecology, 84: 784–788. doi: 10.1111/j.1471-0528.1977.tb12493.x

Author Information

  1. 1

    Royal Free Hospital, Queen Charlotte's Maternity Hospital, London

  2. 2

    Sandoz Products Ltd, Feltham, Middlesex

Publication History

  1. Issue published online: 23 AUG 2005
  2. Article first published online: 23 AUG 2005

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (318K)

Summary

A placebo-controlled, randomized, double-blind, parallel group study in hospital and general practice has shown that a combination of belladonna alkaloids, ergotamine tartrate, and phenobarbitone (Bellergal) was effective in treating troublesome symptoms of the premenstrual syndrome of which fatigue, tender breasts, nervousness, irritability, lethargy and listlessness were improved to a statistically significant degree. The drug was given three times daily and caused no side effects.

Get PDF (318K)